407
Participants
Start Date
July 21, 2014
Primary Completion Date
October 1, 2020
Study Completion Date
October 22, 2024
Futibatinib
oral once daily dosing, 21-day cycle
Cheng Kung University Hospital, Tainan City
National Taiwan University Hospital, Taipei
Roswell Park Cancer Institute, Buffalo
University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh
Hospital of the University of Pennsylvania, Philadelphia
Sidney Kimmel Cancer Center at Jefferson, Philadelphia
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Milan
University of Virginia Cancer Center, Charlottesville
University Hospital Ramón y Cajal, Madrid
Spartanburg Medical Center, Spartanburg
Greenville Health System ITOR,Clinical Research Unit, Greenville
Cancer Treatment Centers of America, Newnan
Institut Bergonie, Bordeaux
Rennes, Centre Eugène Marquis, Rennes
"UOC Oncologia Medica 1 IV - Istituto Oncologico Veneto - IRCCS", Padua
University Hospital Essen, West German Cancer Center, Department of Medical Oncology, Essen
Wayne State Universtity (Karmanos Cancer Institute), Detroit
Medical College of Wisconsin, Milwaukee
University of Wisconsin Clinical Science Center, Madison
Mayo Clinic (MN), Rochester
Cancer Treatment Centers of America Zion, IL, Zion
The University of Kansas Cancer Center, Fairway
Centre Léon Bérard Bât, Lyon
Hospices Civils de Lyon, Bron
Pitié-Salpêtrière Hospital, Paris
Mary Crowley Cancer Research - Medical City, Dallas
The University of Texas MD Anderson Cancer Center, Houston
University of Utah, Huntsman Cancer Hospital, Salt Lake City
Banner MD Anderson Cancer Center, Gilbert
Mayo Clinic (AZ), Scottsdale
The University of Arizona Cancer Center - North Campus, Tucson
New Mexico Cancer Care Alliancer, Albuquerque
City of Hope National Medical Center, Duarte
UCSF Helen Diller Family Comprehensive Cancer Center. Mission Bay, San Francisco
Institute Goustave-Roussy-DITEP, Villejuif
Virginia Mason Cancer Center, Seattle
Massachusetts General Hospital, Boston
Dana Farber Cancer Institution, Boston
Royal Melbourne Hospital, Melbourne
The Chinese University of Hong Kong, Shatin
Centro Integral Oncológico Clara Campal - Hospital Universitario Madrid Sanchinarro, Madrid
Sunnybrook Research Institue, Toronto
Hokkaido University Hospital, Hokkaido
Kyoto University Hospital, Department of Clinical Pharmacology and Therapeutics, Kyoto
Tohoku University Hospital, Miyagi
Osaka International Cancer Institute, Osaka
National Cancer Center Hospital, Tokyo
University Hospital Jenna, Jenna
Yonsei University, Severance Hospital (Seoul), Seoul
ASAN Medical Center (Seoul), Seoul
Samsung Medical Center (Seoul), Seoul
Seoul National University Hospital, Seoul
Val D'Hebron University Hospital, Barcelona
Hospital Clinic i Provincial de Barcelona,, Barcelona
Guy's and St Thomas' NHS Foundation Trust, London
Sarah Cannon Research Institute, London
University College London Hospital, London
The Christie NHS Foundation Trust, Manchester
Taiho Oncology, Inc.
INDUSTRY